Puma Biotechnology Inc. buy Wolf_of_WS
Start price
07.11.19
/
50%
€5.44
Target price
10.11.19
€6.00
Performance (%)
27.80%
End price
10.11.19
€6.95
Summary
This prediction ended on 10.11.19 with a price of €6.95. The BUY prediction by Wolf_of_WS finished with a performance of 27.80%. Wolf_of_WS has 50% into this predictionPuma Biotechnology is a publicly traded biopharmaceutical company that develops innovative cancer therapies targeting the most aggressive and difficult-to-treat forms of the disease. Puma's lead product is Nerlynx, an oral medication approved for the treatment of HER2-positive breast cancer, and the company also has a number of other promising drugs in its pipeline. Founded in 2010, Puma is headquartered in Los Angeles, California, and its shares trade on the NASDAQ exchange under the ticker symbol PBYI.
Performance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Puma Biotechnology Inc. | -7.041% | -7.041% | 75.082% | -43.578% |
| iShares Core DAX® | -1.670% | -1.001% | 10.864% | 12.563% |
| iShares Nasdaq 100 | -4.184% | -1.145% | 37.458% | 41.078% |
| iShares Nikkei 225® | -4.967% | -5.783% | 18.828% | 0.655% |
| iShares S&P 500 | -2.834% | -0.572% | 25.875% | 39.960% |